Abstract

RationaleAggravated airway bronchoconstriction and mucus production in response to allergen and/or bradykinin (i.e., airway hyperresponsiveness) is a primary defining symptom of asthma. Recently, we discovered a critical role for the carotid bodies: inhaled allergen causes an increase in arterial plasma concentrations of asthmakines which excite the carotid bodies via a transient receptor potential vanilloid 1 channel (TRPV1) dependent mechanism. Elevated carotid body excitation in turn increases efferent vagal activity, resulting in heightened bronchoconstriction. While our data demonstrate that the carotid bodies are strongly excited by multiple Th‐2 cytokines, in the ovalbumin primed and sensitized Brown Norway rat model of asthma, the primary asthmakine is likely lysophosphatidic acid (LPA). However, the cellular link between LPA receptors and TRPV1 has not been identified. Here we show that the effect of LPA on the carotid bodies is likely mediated by PKCɛ‐dependent phosphorylation of TRPV1.MethodsLentivirus vectors containing shRNA to knockdown PKCɛ or scrambled sequence were injected bilaterally into the carotid bodies of asthmatic rats (n=7, each). The responses of carotid bodies to LPA (5μM), and their subsequent responses to TRPV1 blockade (AMG9810, 10μM) were tested using the en bloc perfused carotid body preparation. The effects of carotid body‐specific PKCɛ knockdown on changes in lung mechanics in response to inhaled bradykinin were tested using the Flexivent system.ResultsCarotid bodies from asthmatic rats injected with PKCɛ knockdown sequence mounted smaller responses to LPA than those injected with scrambled sequence. No difference in LPA response was detected between groups following TRPV1 blockade, suggesting the primary target for PKCɛ is TRPV1. Asthmatic rats with carotid bodies injected with PKCɛ knockdown sequence had reduced lung resistance in response to bradykinin at 1, 10 and 20 minutes. Similar results were obtained using a PKCɛ inhibitory peptide.ConclusionWe show for the first time that carotid body‐mediated bronchoconstriction in asthmatic rats occurs through LPA receptor activation of PKCɛ and subsequent TRPV1‐mediated carotid sinus nerve excitation. Targeting carotid body LPA receptors, PKCɛ and/or TRPV1 may provide a new therapeutic target to reduce asthmatic airway hyperresponsiveness.Support or Funding InformationCIHR, Alberta Innovates, Alberta Lung Association and the Parker B. Francis Foundation.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call